Friday 16 October 2020

Massachusetts, US-based biopharmaceutical-focussed registry data and analysis services provider Corrona, LLC has acquired UK-based virtual patient community HealthUnlocked to expand patient engagement offerings, the company said.

Terms of the transaction were not disclosed.

HealthUnlocked provides an additional dimension of cultivated data by leveraging a social network of 1.3m patients across hundreds of condition-specific communities, moderated by over 500 patient advocacy groups, capturing insights to better understand what matters most to these patients.

HealthUnlocked will be integrated into Corrona's HealthiVibe business unit to establish an innovative and holistic snapshot of the patient.

By building out its patient experience business, Corrona is working to create an industry-leading ecosystem centred around the patient voice.

This ecosystem directly supports both the 21st Century Cures Act and the FDA's Patient Focussed Drug Development initiative, and establishes Corrona as a leader in patient insights and real-world evidence with both a scalable technology platform, and short- and long-term outcomes and safety data.

Stifel Nicolaus Europe Ltd. acted as exclusive financial advisor to HealthUnlocked.

Corrona provides real world evidence through syndicated registry data and analysis services, helping biopharmaceutical companies demonstrate the value of their products to clinicians, patients, payers, and regulators.

Corrona operates eight major autoimmune registries across the US, Canada, and Japan, collecting data from over 475 participating investigator sites. Corrona is a portfolio company of Audax Private Equity.

HealthUnlocked leverages a social platform to connect 1.3m patients, representing over 300 disease states and conditions with more than 500 patient advocacy groups.